Product Information
- 1,1-Dimethylethyl N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]carbamate
- Boc-Linagliptin
- Carbamic acid, N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester
- Carbamic acid, [(3R)-1-[7-(2-butynyl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester
N-Boc Linagliptin is a drug product that is an analytical standard. It is a synthetic, impurity free API with high purity and pharmacopoeia grade. The CAS No. 668273-75-4 denotes this compound as an N-Boc protected form of Linagliptin. This compound has been developed for its potential use in the treatment of type 2 diabetes mellitus, obesity and related disorders.
Chemical properties
Technical inquiry about: 3D-TBB27375 N-Boc Linagliptin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.